共 50 条
- [1] Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation Bone Marrow Transplantation, 2005, 36 : 793 - 796
- [2] Toxicity and Benefit of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E134 - E135
- [3] Do Patients With Multiple Myeloma Still Need Autologous Stem Cell Transplantation? ONCOLOGY-NEW YORK, 2023, 37 (07): : 309 - 313
- [5] Melphalan and dexamethasone for patients with multiple myeloma who are not candidates for autologous stem cell transplantation NATIONAL MEDICAL JOURNAL OF INDIA, 2007, 20 (03): : 121 - 124
- [9] Autologous Stem Cell Transplantation in Elderly Multiple Myeloma Patients CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E85 - E86